Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
117,273,296
-
Total 13F shares
-
83,711,791
-
Share change
-
+10,475,243
-
Total reported value
-
$822,856,001
-
Put/Call ratio
-
44%
-
Price per share
-
$9.83
-
Number of holders
-
152
-
Value change
-
+$104,874,840
-
Number of buys
-
76
-
Number of sells
-
64
Institutional Holders of DYNAVAX TECHNOLOGIES CORP - Common Stock, $0.001 par value (DVAX) as of Q1 2021
As of 31 Mar 2021,
DYNAVAX TECHNOLOGIES CORP - Common Stock, $0.001 par value (DVAX) was held by
152 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
83,711,791 shares.
The largest 10 holders included
FEDERATED HERMES, INC., Bain Capital Life Sciences Investors, LLC, BlackRock Inc., STATE STREET CORP, Chicago Capital, LLC, VANGUARD GROUP INC, Avidity Partners Management LP, GOLDMAN SACHS GROUP INC, PFM Health Sciences, LP, and BLAIR WILLIAM & CO/IL.
This page lists
152
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.